Summary: The regional distribution of binding sites on the GABAA receptor and their kinetic parameters were measured by quantitative autoradiography in brains from normal rats and rats with a portacaval shunt, a model of portal systemic encephalopathy in which GAB A neuro transmission may be altered. The ligands used were eHlflunitrazepam (a benzodiazepine-site agonist), [3H]_ Ro15-1788 (a benzodiazepine-site antagonist), eH]musci mol (a GABA-site agonist), and eSS]t-butylbicyclo phosphorothionate eSS-TBPS, a convulsant that binds to a site near the chloride channel). Some brains were ana lyzed by computerized image analysis and three dimensional reconstruction. The regional distribution of binding of the benzodiazepines was very similar, but the patterns obtained with eH]muscimol and eSS]TBPS were The GABAA receptor is one of two types of re ceptor that mediate inhibitory GABA neuro transmission throughout the brain. This receptor is a complex oligomeric protein that forms a Cl-ion ophore that is the active component of the receptor.(The other major type of GABA receptor, the GABAB receptor, is not associated with a Cl channel, and is not considered here.) The GABAA receptor is found as a low-affinity and a high affinity type (binding GAB A with mM and nM af finity, respectively). The low-affinity type has a site for benzodiazepine (BZD) binding (Costa et aI. , 1979; Browner et aI. , 1981), and is believed to be the functionally active form (Tallman and Gallagher, For each ligand, the Kd showed a significant heterogene ity among brain regions (at least threefold), contrary to conclusions drawn from earlier studies. In portacaval shunted rats, binding of all four ligands was essentially unchanged from that in control rats, indicating that, if there was an abnormality in GABA neurotransmission during portal systemic shunting, it was not reflected by altered binding to the main sites on the GABAA receptor.